The Fédération Equestre Internationale (FEI) has received notification of an additional doping/medication case at the 2008 Olympic Games. A test carried out on Rufus, mount of Rodrigo Pessoa of Brazil, following the individual show jumping final revealed an A sample that tested positive for the banned substance nonivamide, part of the capsaicinoid family. This is classified as a “doping” prohibited substance given its hypersensitizing properties, and as a “medication class A” prohibited substance for its pain relieving properties.

The sample was received by the laboratory on Aug. 23 following the individual jumping final at which Pessoa and Rufus placed fifth. A preliminary hearing before a member of the FEI Tribunal was held by teleconference Aug. 28 and the suspension was confirmed Aug. 29.

The B sample test is scheduled for Sept. 2 in Hong Kong.

Should the B sample confirm the findings of the A sample the process will follow the accelerated medication control procedure during and after the 2008 Olympic Games, which is part of the FEI’s Regulations for Equestrian Events at the 2008 Olympic Games (Annex G). This is available on FEI Olympic Web site.

Evidence and written submissions will be requested and a hearing will be held before the FEI Tribunal. It is up to the person responsible to determine whether or not they wish to exercise or waive their right to be heard. The panel will then, in light of all the evidence received, make a decision as to the applicable sanction if any.

An update will be provided by the FEI following the result of the B sample, along with further updates regarding the hearing and final decision.

The competition results will be amended as indicated in the tribunal’s final decision.

In terms of testing at the 2008 Olympic Games, all results have now been received, and there are no remaining cases to be reported.

For information